These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4338531)

  • 1. Total haemolytic complement after liver transplantation and in liver disease.
    Pagaltsos AP; Smith MG; Eddleston AL; Williams R
    Transplantation; 1972 Jul; 14(1):41-6. PubMed ID: 4338531
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoglobulin and autoantibody response in acute and chronic liver disease.
    Vittal SB; Dourdourekas D; Shobassy N; Ainis H; Clowdus BF; Steigmann F
    Am J Med; 1974 Oct; 57(4):546-50. PubMed ID: 4372880
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic active liver disease: classification and treatment.
    Soloway RD; Summerskill WH
    Postgrad Med; 1973 Jan; 53(1):88-94. PubMed ID: 4682177
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of serum complement levels in chronic liver disease.
    Finlayson ND; Krohn K; Fauconnet MH; Anderson KE
    Gastroenterology; 1972 Oct; 63(4):653-9. PubMed ID: 4116547
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum immunoglobulins, complement component levels and autoantibodies in liver disease.
    Thompson RA; Carter R; Stokes RP; Geddes AM; Goodall JA
    Clin Exp Immunol; 1973 Jul; 14(3):335-46. PubMed ID: 4199089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of orthotopic liver transplantation on serum-autoantibodies.
    Smith MG; Williams R; Doniach D; Calne RY
    Lancet; 1971 Nov; 2(7732):1006-9. PubMed ID: 4108066
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.
    Teisberg P; Gjone E
    Clin Exp Immunol; 1973 Aug; 14(4):509-14. PubMed ID: 4201114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum complement in chronic liver disease.
    Potter BJ; Trueman AM; Jones EA
    Gut; 1973 Jun; 14(6):451-6. PubMed ID: 4737028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunobiological aspects of blood. Humoral factors of natural resistance].
    Heide K; Schwick HG
    Naturwissenschaften; 1970 Apr; 57(4):179-84. PubMed ID: 4315754
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic liver diseases].
    Räsänen JA; Ahlqvist J
    Duodecim; 1973; 89(2):122-34. PubMed ID: 4685130
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum urocanase as an aid in the differential diagnosis of liver disorders.
    Abramov A; Neufeld E; Chayen R
    Clin Chim Acta; 1969 Feb; 23(2):305-8. PubMed ID: 5764907
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum complement after orthotopic transplantation of the human liver.
    Torisu M; Yokoyama T; Kohler PF; Durst AL; Martineau G; Schroter G; Amemiya H; Groth CG; Starzl TE
    Clin Exp Immunol; 1972 Sep; 12(1):21-30. PubMed ID: 4628404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury.
    Dudley FJ; Fox RA; Sherlock S
    Lancet; 1971 Jul; 2(7714):1-3. PubMed ID: 4103666
    [No Abstract]   [Full Text] [Related]  

  • 14. [The diagnosis of primary biliary cirrhosis (clinical, biochemical, immunological and morphological findings)].
    Brunner G; Vido I; Schmidt G
    Dtsch Med Wochenschr; 1972 Sep; 97(39):1448 passim. PubMed ID: 4560837
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum -fetoprotein in hepatoma patients after liver transplantation.
    Alpert E; Starzl TE; Schur PH; Isselbacher KJ
    Gastroenterology; 1971 Aug; 61(2):144-8. PubMed ID: 4104962
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of abnormalities in host defences against bacterial infection in liver disease.
    Rajkovic IA; Williams R
    Clin Sci (Lond); 1985 Mar; 68(3):247-53. PubMed ID: 2982530
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen.
    Torisu M; Yokoyama T; Amemiya H; Kohler PF; Schroter G; Martineau G; Penn I; Palmer W; Halgrimson CG; Putnam CW; Starzl TE
    Ann Surg; 1971 Oct; 174(4):620-39. PubMed ID: 4999690
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum alcohol dehydrogenase, an indicator of intrahepatic cholestasis.
    Mezey E; Cherrick GR; Holt PR
    N Engl J Med; 1968 Aug; 279(5):241-8. PubMed ID: 5662777
    [No Abstract]   [Full Text] [Related]  

  • 19. Positive tissue antibody tests in patients with prolonged extrahepatic biliary obstruction.
    Lam KC; Mistilis SP; Perrott N
    N Engl J Med; 1972 Jun; 286(26):1400-1. PubMed ID: 4555302
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitochondrial antibody in primary biliary cirrhosis and other diseases.
    Klatskin G; Kantor FS
    Ann Intern Med; 1972 Oct; 77(4):533-41. PubMed ID: 4566006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.